SCHEMBL6064797

SCHEMBL6064797

COCC(=O)C1CNCCN1c1nc(N)nc2ncc(-c3ccc(OC)c(OC)c3)nc12

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 6/20 0.56
NEK2 P51955 2/20 0.43
STK17B O94768 2/20 0.39
GAK O14976 2/20 0.39
PDE4D Q08499 2/20 0.37
PDE4A P27815 1/20 0.37
PDE4B Q07343 1/20 0.37
PDE4C Q08493 1/20 0.37
MAP4K1 Q92918 1/20 0.37
SYK P43405 1/20 0.37
MAP3K11 Q16584 2/20 0.36
STK17A Q9UEE5 1/20 0.36
PI4KB Q9UBF8 1/20 0.35
MTOR P42345 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5464734 0.93 NOS1 (0.57) NOS1NEK2STK17BGAKPDE4D
SCHEMBL6064705 0.90 NOS1 (0.60) NOS1NEK2STK17BGAKPDE4D
SCHEMBL5478328 0.89 NOS1 (0.53) NOS1NEK2STK17BGAKPDE4D
SCHEMBL5469822 0.88 NOS1 (0.62) NOS1NEK2STK17BGAKPDE4D
SCHEMBL5471635 0.88 NOS1 (0.52) NOS1NEK2STK17BGAKPDE4D
SCHEMBL5461841 0.88 NOS1 (0.55) NOS1NEK2STK17BGAKPDE4D
SCHEMBL5614813 0.88 NOS1 (0.53) NOS1NEK2STK17BGAKPDE4D
SCHEMBL5461814 0.87 NOS1 (0.56) NOS1NEK2STK17BGAKPDE4D
SCHEMBL5478226 0.86 NOS1 (0.55) NOS1NEK2STK17BGAKPDE4D
SCHEMBL5463717 0.86 NOS1 (0.59) NOS1NEK2STK17BGAKPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1673092-A1 HETEROCYCLE-SUBSTITUTED PTERIDINE DERIVATIVES AND THEIR USE IN THERAPY 4 AZA Bioscience nv (BE) 2006-06-28 EP disclosed
WO-2005039587-A1 HETEROCYCLE-SUBSTITUTED PTERIDINE DERIVATIVES AND THEIR USE IN THERAPY 4 AZA BIOSCIENCE NV (BE) 2005-05-06 WO disclosed